PYXS Pyxis Oncology Inc
Company Analysis
Latest News
Pyxis Oncology Sees GordonMD Raise Stake to Nearly 28 Million Shares
GordonMD Global Investments LP disclosed on October 9, 2026, that it had significantly increased its position in Pyxis Oncology. The firm acquired nearly 18...
🔴 Pyxis Oncology is trading 5% down
Pyxis Oncology is trading 5.07% down at $1.91 on October 8, 2026; no clear driver is established. - No company announcement dated October 7 or 8 appeared in...
🟢 Pyxis Oncology is trading 5.4% up in after-hours trading — catalyst unclear
Pyxis Oncology is trading 5.38% up in after-hours at $2.13, with no new company-specific announcement identified to explain the rise. - The October 6...
🔴 Pyxis Oncology is trading 10% down; no clear direct catalyst identified
Pyxis Oncology is trading 10.04% lower at $2.02 on October 6, 2026, with no clearly established direct catalyst in available evidence. - No new...
🔴 Pyxis Oncology is trading 5% down today with biotech-sector weakness a possible backdrop
Pyxis Oncology is trading at $2.12, down 5.13%, with biotech-sector pressure a possible backdrop. - XBI fell 2.50% during the session, offering a possible...
🟢 Pyxis Oncology is trading 5% up with no identified catalyst
Pyxis Oncology is trading 5.14% higher at $2.25 on October 5, 2026, with no company-specific announcement or report identified to explain the intraday rise. -...
Pyxis Oncology Closes Approx. $102.8 Million Public Offering to Fund Clinical Trials
Pyxis Oncology, Inc. announced the closing of an underwritten public offering, generating net proceeds of approximately $102.8 million. The capital will...
🔴 Pyxis Oncology is trading 5.8% down today after pricing a dilutive public offering
Pyxis Oncology is trading 5.8% down at $2.19 after pricing a dilutive public offering. - The offering includes 36,047,919 shares and warrants for 49,310,352...
Pyxis Oncology Raises $110 Million in Dilutive Offering — But Can the Cash Fuel a Phase 3 Comeback?
Shares of Pyxis Oncology (PYXS) slid 8.6% to $2.65 in early trading Tuesday after the clinical-stage biotech priced a public offering of shares and warrants...
🔴 Pyxis Oncology is trading 19.31% down today after pricing a $110 million public offering
Pyxis Oncology is trading 19.31% lower at $2.34 after pricing a public offering expected to raise approximately $110 million. - The deal pairs shares or...
🔴 Pyxis Oncology is trading 10.34% down in pre-market after pricing a $110 million offering with warrants
Pyxis Oncology is trading at $2.60, down 10.34%, after pricing a public offering expected to raise approximately $110 million before offering expenses. - The...
🔴 Pyxis Oncology is trading 8.62% down in pre-market after pricing a $110 million offering
Pyxis Oncology is trading at $2.65, down 8.62% in pre-market after pricing a public offering expected to raise approximately $110 million. - On September 30,...
Pyxis Oncology Launches Offering to Fund Planned MICVO Phase 3 Trial
Pyxis Oncology (NASDAQ: PYXS) has commenced a registered public offering of common stock, pre-funded warrants and accompanying common warrants to purchase...
🔴 Pyxis Oncology is trading 8.3% down in after-hours trading as catalyst remains unclear
Pyxis Oncology is trading at $2.66, down 8.27%, after hours; the reason for the decline remains unclear. - No clearly identified company-specific announcement...
🔴 Pyxis Oncology is trading 11% down today amid macro-driven biotech selling
Pyxis Oncology is trading 11.02% lower at $2.87 as broader biotech and macroeconomic pressure weigh on shares; no new company-specific announcement emerged to...
🔴 Pyxis Oncology is trading 5.6% down today amid higher yields, oil prices and inflation concerns
Pyxis Oncology is trading 5.6% lower at $3.04 amid a broader biotech sell-off. • Biotech ETF XBI is down 2.04% during regular trading as higher Treasury...
🟢 Pyxis Oncology is trading 5% up today
Pyxis Oncology is trading 5.02% up at $3.35, with no confirmed explanation identified for this session’s move. - No new company-specific announcement,...
🔴 Pyxis Oncology is trading 5.25% down today as risk-off pressure hits growth stocks and biotech
Pyxis Oncology is trading 5.25% down at $3.25 as broader risk-off pressure hits growth stocks and biotechnology on September 15, 2026. - The 10-year Treasury...
🟢 Pyxis Oncology is trading 5.6% up today + H.C. Wainwright presentation
Pyxis Oncology is trading 5.6% up at $3.37, supported by its 9:30 a.m. H.C. Wainwright conference presentation and recent analyst optimism on September 14,...
🟢 Pyxis Oncology is trading 6.54% up today amid H.C. Wainwright conference anticipation
Pyxis Oncology is trading 6.54% up at $3.42, with H.C. Wainwright conference anticipation the most plausible support, though the immediate catalyst remains...